Cartesian Therapeutics CVR
13F holders, Q2 2024 (June 30)3holders
0new positions
0sold out
$0.13avg. 13F price*
At the end of Q2 2024, 3 institutions reported holding Cartesian Therapeutics CVR in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Erste Asset Management GmbH ($343K), Ironwood Investment Management LLC ($0) and GAMMA Investing LLC ($0).
- Company
- Cartesian Therapeutics CVR
- CUSIP
- 816212112
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 3 holders
| Erste Asset Management GmbH | 0.00% | No change | 2,527,000 | $343K |
| Ironwood Investment Management LLC | 0.00% | No change | 173,208 | $0 |
| GAMMA Investing LLC | 0.00% | No change | 237 | $0 |
"% of holder's portfolio" is Cartesian Therapeutics CVR's weight in each manager's 13F, not the share of Cartesian Therapeutics CVR the manager owns.